Nutritional, Metabolic, Endocrine
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants who have been diagnosed and are being managed for type 2 DM at the endocrinology clinic for at least 1 year Participants who have been on oral hypoglycaemic agents with or without insulin therapy for at least 1 year Participants who have moderate to severe chronic periodontitis as evidenced by =2 interproximal sites with pocket depth =5mm (not on same tooth) according to Centres for Disease Control and Prevention in partnership with the American Academy of Periodontology, 2005; modified by Eke and Page, 2012.33 Participants must have minimum of 20 teeth Body Mass Index <30 Participants who have neither smoked cigarette nor quit cigarette smoking < 5 years
Exclusion criteria
Exclusion criteria: Current smokers Pregnancy Known cases of immunosupression (Immunosuppressive drugs, tuberculosis, malnutrition, Acquired Immuned Deficiency State, long-term steroid use) Participants who had undergone non-surgical periodontal therapy in the last six months Long term use of anti-inflammatory medications/antibiotics in the last six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycaemic control as measured by the level of glycated haemoglobin was the primary outcome. Secondary outcomes are probing pocket depth and clinical attachment loss for the measurement of periodontal status | — |
Secondary
| Measure | Time frame |
|---|---|
| Periodontal status measured by clinical attachment loss and probing pocket depth | — |
Countries
Nigeria
Contacts
Senior Lecturer and Consultant Periodontologist Obafemi Awolowo univerity Ile Ife